SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects | MicrobiomeTrials← Back to trialsNCT05902962
SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2023-04-20Est. Completion: 2025-08-08
Enrollment target: 17 participants Locations- University of Florida Health, Jacksonville, Florida, United States
- Bascom Palmer Eye Institute University of Miami, Miami, Florida, United States
- University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
- Oregon Health and Science University - Casey Eye Institute, Portland, Oregon, United States
- Retina Foundation of the Southwest, Dallas, Texas, United States
- Baylor College of Medicine- Alkek Eye Center, Houston, Texas, United States
Other microbiome trials you might be interested in
Retinitis Pigmentosa Syndrome
Retinopathy pigmentosa (which affects about 40,000 patients in France) leads to destruction of the peripheral retina. Th…
Multiple LocationsCompleted Oct 2022
Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal DystrophyBlue-cone MonochromacyBest DiseaseAniridiaAlbinism
Background:
The eyeGENE (Registered Trademark) program is a research resource for inherited eye conditions which includ…
Bethesda, United StatesEst. completion Jun 27, 2054
Stargardt-Like Macular Dystrophy
Background:
STDG3 is an inherited eye disease. Currently there is no treatment for STDG3. Past studies of STDG3 have la…
Bethesda, United StatesEst. completion Jul 16, 2028